CBG Benefits

CBG Benefits Cannabigerol

Cannabigerol (CBG) is one of over 120 identified cannabinoids found in the Cannabis Sativa plant.

Much of the attention in recent years in the scientific community has been largely focused on the therapeutic benefits of popular cannabinoids such as CBD (Cannabidiol) and THC.

However, CBG is another safe, non-toxc, non-psychoactive cannabinoid which may possess a range of biological activities including anti-bacterial activity, neuroprotective and even potentially anti-tumor effects.

Cannabigerol (CBG) serves as the precursor molecule for the most abundant phytocannabinoids and is often referred to as “the mother of all cannabinoids”.

CBG is a minor constituent of the Cannabis Sativa plant present in very low amounts of less than 10% of the cannabinoid fraction.

CBG is potentially unique compared to other cannabinoids due to it’s interactions with α-2 adrenoceptors and 5-hydroxytryptamine (5-HT1A). [1]

Here are five Cannabigerol (CBG) benefits backed by the science.

CBG Health Benefits

1. Anti-Bacterial Properties

Cannabigerol CBG Anti-Bacterial

Research has discovered that certain cannabinoids exert anti-microbial activity against gram-positive bacteria.

One of these is Cannabigerol (CBG), a non-psychoactive cannabinoid which has shown anti-bacterial effect against the likes of Streptococcus mutans (S. mutans), the most common pathogen associated with tooth caries. [2]

Cannabigerol (CBG) is a potent antibacterial, antibiofilm, and antipersister cannabinoid. 

Studies have also found CBG to exhibit antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).

The mechanisms of action of CBG is thought to be by inhibiting its ability to form biofilms, eradicating preformed biofilms and stationary phase cells persistent to antibiotics. [3]

2. Anti-Tumor Effects

Cannabigerol CBG Anti-Tumor Effects

The interest in cannabinoids such as delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) as potential adjunct cancer therapies continues to grow.

Recently Cannabigerol (CBG) has shown anti-tumor properties in certain carcinomas such as colorectal cancer (CRC), breast cancer and glioblastoma.

Cannabigerol, O-1602, and URB-602 demonstrated a high capacity for tumor volume reduction.

Induction of apoptosis, interaction with cell survival, growth pathways, and angiogenesis inhibition were the mechanisms extracted from the studies that explain cannabinoids’ actions on CRC. [4]

3. Neuroprotective & Neuroinflammation

Cannabigerol CBG Neuroprotective

Cannabigerol (CBG) has shown potential neuroprotective properties in experimental models of neurological disease.

Safe, non-psychoactive, neuroprotective Cannabinoids such as CBG may potentially be of significant benefit in the treatment of neurological disorders such as (Huntington disease, Parkinson disease, and multiple sclerosis).

Recently our group conducted a systematic review focusing on the neuroprotective properties of minor phytocannabinoids (other than Δ9-THC or CBD) and found that CBG and CBDV show efficacy in models of Huntington’s disease, Alzheimer’s, and epilepsy, with CBG mediating its protective effects through PPAR-γ activation, the same mechanism by which we have shown that CBD protects BBB integrity.

The study also found that: CBG and CBDV were protective against OG mediated injury in three different cells that constitute the BBB, modulating different hallmarks of ischemic stroke pathophysiology. [8]

CBG is thought to exert its neuroprotective effect through numerous different mechanisms such as attenuating the reactive microgliosis, the upregulation of inflammatory markers/reducing (IL-1β, TNF-α, IFN-γ) and improving antioxidant defenses.

4. Appetite Stimulant

The appetite-stimulating properties of the Cannabis Sativa plant are well documented and research has found that Cannabis extracts devoid of THC still stimulate appetite, indicating that other cannabinoids or compounds can also elicit hyperphagia.

CBG is currently being studied for its appetite boosting properties and animal studies in rats have found that:

CBG elicits hyperphagia, by reducing latency to feed and increasing meal frequency, without producing negative neuromotor side effects. [10]

5. Analgesic & Pain Relief

Some studies have described Cananbigerol (CBG) as having stronger analgesic and pain relieving effect than the popular cannabinoid delta-9-tetrahydrocannabinol (THC).

Much like CBD (Cannabidiol), Cannabigerol may be another promising non-psychoactive cannabinoid for the management of difficult to treat and chronic pain disorders.

Furthermore, CBG has more potent analgesic, anti-erythema and lipooxygenase blocking activity than THC. [11]

Where To Purchase CBG Products?

CBG Products

Ghost CBD stock a range of Cannabigerol CBG Products including CBG Oils, CBG Capsules and CBG Vape Liquids.

Some of these include The Herb Kingdom 500mg CBG Oil, 1000mg CBG/CBD Capsules and 1000mg CBG/CBD Oil Formulas.

CBG Vape E-Liquids are also available in 1500mg strength CBG E-Liquids from Voodoo Hemp in two flavours OG Kush and Pineapple Express.

Another brand and product range I would highly recommend checking out is cbme personalised CBD dried fruit including their Uplift, Relax and Relieve.

cbme’s unique tasty personalised dried fruit combine the benefits of CBD (Cannabidiol) and CBG together, then infuse with supporting herbal elements and nutrients.


[1] The Pharmacological Case for Cannabigerol

[2] Anti-Bacterial Properties of Cannabigerol Toward Streptococcus mutans

[3] Uncovering the Hidden Antibiotic Potential of Cannabis

[4] Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma

[5] Meta-Analysis of Cannabigerol Effects on Breast Cancer

[6] Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid

[7] Cannabinoid Effects on Experimental Colorectal Cancer Models Reduce Aberrant Crypt Foci (ACF) and Tumor Volume: A Systematic Review

[8] Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions

[9] In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid

[10] Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats

[11] Cannabinoids in the management of difficult to treat pain

The information in this article has not been evaluated by the FDA and should not be used to diagnose, cure or treat any disease, implied or otherwise.

Always consult a medical professional before taking any dietary supplements, herbs or medication.


Get 25% Off Your Order At Orange County CBD with our discount code: THECBDBLOG

Orange County CBD

Be the first to comment

Leave a Reply

Your email address will not be published.